Scientists from the University of Queensland and the University of New South Wales have developed paramedic cyborg cockroaches, or "paraborgs," equipped with miniature injection devices and cameras. The research aims to use the insects to deliver lifesaving drugs to people trapped in narrow, debris-filled spaces during disasters.

Researchers in Australia have developed paramedic cyborg cockroaches, known as "paraborgs," equipped with miniature injection devices and cameras. Scientists from the University of Queensland and the University of New South Wales hope the insects could one day assist search-and-rescue teams by delivering basic medical assistance to people trapped after earthquakes and building collapses before human rescuers arrive.

According to the study published in the journal Advanced Science, the research team utilized North Queensland giant burrowing cockroaches, noted as the heaviest cockroach species in the world, measuring up to 8.5 centimetres. Researchers fitted the insects with backpacks containing syringe cylinders and cameras. While earlier cyborg insect research has focused primarily on locating victims, this study extends the application to medical treatment.

Researchers stated that real cockroaches were chosen because artificial robots cannot match their agility, resilience, and low power requirements. The system relies on implanted electrodes that allow operators to stimulate the nervous system of the insects to steer them. Biorobotics engineer and study co-author Thang Vo-Doan explained that the insects are first anaesthetised and immobilised before the implantation process, after which small electrical signals are applied to guide their movement.

The experimental setup utilized one observer cockroach equipped with a camera to locate targets, and a second cockroach carrying the medication to be remotely triggered. Laboratory tests conducted using silicone targets and pig skin recorded a 100% success rate in reaching designated checkpoints and an overall drug-delivery success rate of 72%. When the injection was launched from within 15 centimetres of a target, the success rate increased to 95%.

The study indicates that such systems could eventually be deployed to stabilise victims in time-sensitive situations, such as snake bite emergencies and severe allergic reactions. Future plans include deploying a swarm of cockroaches deep into collapsed structures using a networked approach to locate victims more efficiently.

Despite the successful laboratory trials, researchers noted that further testing is required to address real-world challenges, including navigating complex terrain, managing signal loss within collapsed structures, and ensuring injection safety. Regarding ethical considerations, while formal research guidelines for insects remain unstandardised, the study noted that the cockroaches were maintained in a suitable living environment and fed dry gum leaves and apples during the research.

"This research highlights the practical integration of biological capabilities with advanced engineering to solve critical real-world challenges in emergency response. While the application is currently in a controlled laboratory phase with technical and real-world hurdles ahead, the intersection of robotics, biotechnology, and disaster management opens up interesting avenues for specialized hardware and niche deep-tech development. Investors and innovators watching the deep-tech sector should note how unconventional methodologies are increasingly being explored to address high-stakes logistical problems." — Dr. Shishir Gupta, Founder & CEO, StartupLanes

Recent StartupLanes Articles

Browse through our 30 latest publications on venture capital, startups, and angel investing.

Netflix Records Highest Paid Subscriber Net Additions in India for Q3 Oct 22, 2026
Kalpataru Projects International Secures New Orders Worth ₹2,349 Crore Oct 22, 2026
MCX Copper Futures Decline From Recent Highs as Market Approaches Key Support Levels Oct 22, 2026
OpenAI Acquires Orchestra Bio to Expand Life Sciences and Drug Development Capabilities Oct 22, 2026
Dr. Reddy’s Laboratories Receives DCGI Approval for Toripalimab in India Oct 22, 2026
Anthropic's Confidential IPO Filing Reveals $80.7 Billion H1 Loss and Heavy Computing Costs Oct 22, 2026
Jio Platforms Launches ₹30,213 Crore IPO: Key Details, Valuations, and Brokerage Views Oct 22, 2026
State Bank of India Reports Suspected Customer Data Exposure on Dark Web Oct 22, 2026
US Secretary of State Marco Rubio Terms Envoy Meeting with Ukrainian President Positive Oct 22, 2026
Rupee Strengthens 29 Paise Against US Dollar in Early Trade, Supported by RBI and Jio IPO Inflows Oct 22, 2026
Brent Crude Stays Above $110 Amid West Asia Supply Concerns and Inventory Data Oct 22, 2026
Indian Market Updates: Corporate Earnings, Strategic Agreements, and Expansion Plans Across Sectors Oct 22, 2026
Corporate Updates: Infosys Expands Truist Collaboration, Cemindia Raises ₹1,400 Crore via QIP, and Multiple Firms Report Contracts and Acquisitions Oct 22, 2026
Centre to Review National Mineral Policy 2019 to Focus on Critical Minerals and Deep-Sea Resources Oct 22, 2026
Qualcomm Announces Global Job Cuts Following Annual Performance Reviews Oct 22, 2026